South Korea-based healthcare startup Sky Labs has attracted investments with OMRON Ventures, Omron Group's enterprise-led venture capital (CVC). This means strengthening strategic partnerships for global business expansion beyond simple financial investment.
In addition, it has also signed a Memorandum of Understanding (MoU) with OMRON Healthcare, a global blood pressure monitoring market leader, regarding strengthening its strategic partnership.
The strengthening of the partnership is the result of Sky Labs' "CART BP," demonstrating confidence in its growth potential related to preventing chronic diseases and expanding its global business.
In 2024, the two companies signed a MoU for global distribution and business development of "CART BP," and also signed a Japanese market distribution contract for prior products.
Sky Labs successfully commercialised the world's first cuffless ring-type blood pressure monitoring 'CART BP'. The biggest feature of "Cart BP" is that it can continuously measure daily, sleep, and night blood pressure data to prevent high blood pressure and cardiovascular disease.
In addition, it is possible to check changes and trends in blood pressure by time, date, and month during daily life, away from the existing clinic and outpatient measurement center.
As of 2025, global cumulative blood pressure monitoring sales exceeded 400 million units, and Omron is continuing to develop innovative products and solutions to ensure accurate and continuous blood pressure management at home.
